Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: I think RG anticipates a higher share price.

S & L was an act of desparation by PTSC. PTSC wanted to stay in business. S & L took a no loss vs incredible rewards position and it worked out for them. In their view it was PTSC shareholders be damned.



Now we are in a postion to, yes, dilute the shares of the company. But with the possibility to increase eanings. IMHO, we are in a radically differentand positive territory than in the S & L days.



Share
New Message
Please login to post a reply